Konstantinides SV - Search Results

1

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

Klok FA, Ageno W, Barco S, Binder H, Brenner B, Duerschmied D, Empen K, Faggiano P, Ficker JH, Galiè N, Ghuysen A, Held M, Heydenreich N, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Münzel T, Petris A, Pruszczyk P, Quitzau K, Schellong S, Schmidt KH, Stefanovic BS, Verschuren F, Wolf-Puetz A, Meyer G, Konstantinides SV; PEITHO-2 Investigators. Klok FA, et al. Among authors: konstantinides sv. Thromb Haemost. 2017 Dec;117(12):2425-2434. doi: 10.1160/TH17-06-0434. Epub 2017 Dec 6. Thromb Haemost. 2017. PMID: 29212130

2

Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.

Puls M, Dellas C, Lankeit M, Olschewski M, Binder L, Geibel A, Reiner C, Schäfer K, Hasenfuss G, Konstantinides S. Puls M, et al. Eur Heart J. 2007 Jan;28(2):224-9. doi: 10.1093/eurheartj/ehl405. Epub 2006 Nov 24. Eur Heart J. 2007. PMID: 17127709

3

Possible gender-related differences in the risk-to-benefit ratio of thrombolysis for acute submassive pulmonary embolism.

Geibel A, Olschewski M, Zehender M, Wilsch M, Odening K, Heinrich F, Kasper W, Konstantinides S. Geibel A, et al. Am J Cardiol. 2007 Jan 1;99(1):103-7. doi: 10.1016/j.amjcard.2006.07.072. Epub 2006 Nov 9. Am J Cardiol. 2007. PMID: 17196471

4

Leptin signalling and leptin-mediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2.

Dellas C, Schäfer K, Rohm IK, Lankeit M, Leifheit M, Loskutoff DJ, Hasenfuss G, Konstantinides SV. Dellas C, et al. Among authors: konstantinides sv. Thromb Haemost. 2007 Nov;98(5):1063-71. Thromb Haemost. 2007. PMID: 18000612

5

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

Lankeit M, Kempf T, Dellas C, Cuny M, Tapken H, Peter T, Olschewski M, Konstantinides S, Wollert KC. Lankeit M, et al. Am J Respir Crit Care Med. 2008 May 1;177(9):1018-25. doi: 10.1164/rccm.200712-1786OC. Epub 2008 Feb 8. Am J Respir Crit Care Med. 2008. PMID: 18263797

6

Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity.

Dellas C, Schäfer K, Rohm I, Lankeit M, Ellrott T, Faustin V, Riggert J, Hasenfuss G, Konstantinides S. Dellas C, et al. Thromb Haemost. 2008 Dec;100(6):1123-9. Thromb Haemost. 2008. PMID: 19132239

7

Desmoteplase in acute massive pulmonary thromboembolism.

Tebbe U, Bramlage P, Graf A, Lechleitner P, Bode C, Riess FC, Clemens N, Al-Rawi Y, Konstantinides S, Goldhaber SZ. Tebbe U, et al. Thromb Haemost. 2009 Mar;101(3):557-62. Thromb Haemost. 2009. PMID: 19277420 Clinical Trial.

8

Thrombolysis for hemodynamically stable patients with pulmonary embolism: still searching for the intermediate-risk group.

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Res. 2009 Dec;124(6):647-8. doi: 10.1016/j.thromres.2009.07.002. Epub 2009 Aug 6. Thromb Res. 2009. PMID: 19664803 No abstract available.

9

Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Res. 2010 Dec;126(6):e407-8. doi: 10.1016/j.thromres.2009.10.010. Epub 2009 Nov 6. Thromb Res. 2010. PMID: 19896704 No abstract available.

10

Thrombolysis for pulmonary embolism: Past, present and future.

Lankeit M, Konstantinides S. Lankeit M, et al. Thromb Haemost. 2010 May;103(5):877-83. doi: 10.1160/TH10-01-0005. Epub 2010 Mar 9. Thromb Haemost. 2010. PMID: 20216979 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page